Retatrutide is not registered in South Africa, and mobivIVe does not offer it. It is an investigational medicine still in clinical trials. This page explains what it is, what the research shows, why products sold online as retatrutide are a risk, and which registered treatments are available, reviewed by a registered doctor.
Reviewed by Dr Chris van Zyl (registered as M.C. van Zyl, HPCSA MP0287067), who consults patients himself and dispenses under his own Section 22C dispensing licence.
What is retatrutide?
Retatrutide is an experimental once-weekly injection developed by Eli Lilly. It acts on three hormone receptors (GLP-1, GIP and glucagon), where semaglutide acts on one and tirzepatide on two. It is being studied for obesity, type 2 diabetes and related conditions.
Is retatrutide available in South Africa?
No. Retatrutide has not been registered by SAHPRA, and it has not been approved by any major medicines regulator. It cannot legally be prescribed or sold as a medicine in South Africa. Anything advertised online as retatrutide is unregistered material of unknown origin, purity and strength. SAHPRA has issued public warnings about unregistered weight loss products sold through social media, gyms and salons.
What does the research show?
In a phase 2 trial published in the New England Journal of Medicine, people on the highest dose lost an average of 24.2% of their body weight after 48 weeks. Larger phase 3 trials (the TRIUMPH programme) reported results in 2026, with substantial average weight loss. Side effects were mainly gastrointestinal, similar to other medicines in this class. Long-term safety is still being studied.
When will retatrutide be available in South Africa?
There is no confirmed date. A medicine first needs approval from a regulator after its phase 3 trials, and then a separate SAHPRA registration before it can be sold here, which usually takes years. We will update this page when its status changes.
What can I use instead of retatrutide?
Two registered options are available now on a doctor’s script. Semaglutide, including Semagard and Ozempic, and tirzepatide (Mounjaro), a dual-action medicine that generally produces more weight loss.
How do I start?
Message our team on WhatsApp. You will have a telephone or video consultation with our registered doctor, who decides which registered treatment is clinically appropriate for you. If a script is issued, your treatment is couriered discreetly anywhere in South Africa.
How to start, in 3 simple steps
- Message us on WhatsApp. Tell our doctor-led team your goal.
- Doctor consultation. A telephone or video consultation with our registered doctor, who assesses your suitability and issues a script if the treatment is right for you.
- Delivered to your door. Your prefilled pen is couriered anywhere in South Africa, with clear dosing instructions.
More on weight loss injections: Weight loss injections compared · Mounjaro price · Ozempic price · Semagard · Semaglutide · Wegovy
Medically reviewed by Dr Chris van Zyl This page was written and reviewed by the mobivIVe medical team, led by Dr Chris van Zyl, an HPCSA-registered medical doctor (registered as M.C. van Zyl, HPCSA reg. no. MP0287067) who is licensed to both prescribe and dispense medicines under a Section 22C dispensing licence. Last reviewed November 2026. Brand names are the property of their respective owners and are used here for identification only. Not intended to diagnose, treat, cure or prevent any disease; individual results vary.